Virtual Medicinal Product (VMP) - Ranibizumab 2.3mg/0.23ml solution for injection vials
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Ranibizumab 2.3mg/0.23ml solution for injection vials | Start Date 30-09-2008 | End Date |
| Previous Name | Previous Name Ranibizumab 2.3mg/0.23ml solution for inection vials | Start Date 17-09-2008 |
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 0.23
- UDFS UOM
- ml
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Caution - AMP level prescribing advised
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravitreal
- Form
- Solution for injection
- Ontology Form/Route
- solutioninjection.intravitreal
- Non-availability Indicator
- Actual Products Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- S01LA04
- BNF Codes
-
- BNF code 11080200
| Code | Start Date | End Date |
|---|---|---|
| 14057611000001107 | 17-09-2008 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Ranibizumab | Based on Ingredient Substance | 10 mg | 1 ml |
Name
Ranibizumab
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
10
Strength and UOM (Dmr)
1
Parent Products
-
VTMRanibizumab
-
VMP(Current) Ranibizumab 2.3mg/0.23ml solution fo...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 vial |